Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 277

1.

Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.

Reiberger T, Ferlitsch A, Payer BA, Pinter M, Homoncik M, Peck-Radosavljevic M; Vienna Hepatic Hemodynamic Lab.

J Gastroenterol. 2012 May;47(5):561-8. doi: 10.1007/s00535-011-0517-4. Epub 2011 Dec 15.

PMID:
22170417
2.

Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.

Villanueva C, Aracil C, Colomo A, Hernández-Gea V, López-Balaguer JM, Alvarez-Urturi C, Torras X, Balanzó J, Guarner C.

Gastroenterology. 2009 Jul;137(1):119-28. doi: 10.1053/j.gastro.2009.03.048. Epub 2009 Apr 1.

PMID:
19344721
3.

Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.

Bañares R, Moitinho E, Piqueras B, Casado M, García-Pagán JC, de Diego A, Bosch J.

Hepatology. 1999 Jul;30(1):79-83.

PMID:
10385642
4.

Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.

Reiberger T, Ulbrich G, Ferlitsch A, Payer BA, Schwabl P, Pinter M, Heinisch BB, Trauner M, Kramer L, Peck-Radosavljevic M; Vienna Hepatic Hemodynamic Lab.

Gut. 2013 Nov;62(11):1634-41. doi: 10.1136/gutjnl-2012-304038. Epub 2012 Dec 18.

PMID:
23250049
5.

Shear-wave elastography: a noninvasive tool for monitoring changing hepatic venous pressure gradients in patients with cirrhosis.

Choi SY, Jeong WK, Kim Y, Kim J, Kim TY, Sohn JH.

Radiology. 2014 Dec;273(3):917-26. doi: 10.1148/radiol.14140008. Epub 2014 Jul 14.

PMID:
25025464
6.

Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study.

Robic MA, Procopet B, Métivier S, Péron JM, Selves J, Vinel JP, Bureau C.

J Hepatol. 2011 Nov;55(5):1017-24. doi: 10.1016/j.jhep.2011.01.051. Epub 2011 Feb 25.

PMID:
21354450
7.

Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.

Merkel C, Bolognesi M, Berzigotti A, Amodio P, Cavasin L, Casarotto IM, Zoli M, Gatta A.

J Hepatol. 2010 Jan;52(1):45-53. doi: 10.1016/j.jhep.2009.10.014. Epub 2009 Oct 23.

PMID:
19914730
8.

Acute and 7-day portal pressure response to carvedilol and propranolol in cirrhotics.

De BK, Das D, Sen S, Biswas PK, Mandal SK, Majumdar D, Maity AK.

J Gastroenterol Hepatol. 2002 Feb;17(2):183-9.

PMID:
11966949
9.

Octreotide enhances portal pressure reduction induced by propranolol in cirrhosis: a randomized, controlled trial.

Vorobioff JD, Ferretti SE, Zangroniz P, Gamen M, Picabea E, Bessone FO, Reggiardo V, Diez AR, Tanno M, Cuesta C, Tanno HE.

Am J Gastroenterol. 2007 Oct;102(10):2206-13. Epub 2007 Jun 29.

PMID:
17608776
10.

Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.

La Mura V, Abraldes JG, Berzigotti A, Erice E, Flores-Arroyo A, García-Pagán JC, Bosch J.

Hepatology. 2010 Jun;51(6):2108-16. doi: 10.1002/hep.23612.

PMID:
20512998
11.

A randomized study of losartan vs propranolol: Effects on hepatic and systemic hemodynamics in cirrhotic patients.

Castaño G, Viudez P, Riccitelli M, Sookoian S.

Ann Hepatol. 2003 Jan-Mar;2(1):36-40.

PMID:
15094704
12.

Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors.

Llop E, Berzigotti A, Reig M, Erice E, Reverter E, Seijo S, Abraldes JG, Bruix J, Bosch J, García-Pagan JC.

J Hepatol. 2012 Jan;56(1):103-8. doi: 10.1016/j.jhep.2011.06.027. Epub 2011 Aug 7.

PMID:
21827733
13.

Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.

La Mura V, Abraldes JG, Raffa S, Retto O, Berzigotti A, García-Pagán JC, Bosch J.

J Hepatol. 2009 Aug;51(2):279-87. doi: 10.1016/j.jhep.2009.04.015. Epub 2009 May 24.

PMID:
19501930
14.

Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.

Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J; Portal Hypertension Collaborative Group.

Gastroenterology. 2007 Aug;133(2):481-8. Epub 2007 May 21.

PMID:
17681169
15.

Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.

Abraldes JG, Albillos A, Bañares R, Turnes J, González R, García-Pagán JC, Bosch J.

Gastroenterology. 2009 May;136(5):1651-8. doi: 10.1053/j.gastro.2009.01.043. Epub 2009 Jan 24.

PMID:
19208350
16.

Carvedilol or propranolol in portal hypertension? A randomized comparison.

Hobolth L, Møller S, Grønbæk H, Roelsgaard K, Bendtsen F, Feldager Hansen E.

Scand J Gastroenterol. 2012 Apr;47(4):467-74. doi: 10.3109/00365521.2012.666673. Epub 2012 Mar 9.

PMID:
22401315
17.

Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.

Kim MY, Baik SK, Park DH, Lim DW, Kim JW, Kim HS, Kwon SO, Kim YJ, Chang SJ, Lee SS.

Liver Int. 2007 Oct;27(8):1103-10.

PMID:
17845539
18.

[Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].

Kim MY, Baik SK, Suk KT, Yea CJ, Lee IY, Kim JW, Cha SH, Kim YJ, Um SH, Han KH.

Korean J Hepatol. 2008 Jun;14(2):150-8. doi: 10.3350/kjhep.2008.14.2.150. Korean.

19.

Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease.

Bureau C, Metivier S, Peron JM, Selves J, Robic MA, Gourraud PA, Rouquet O, Dupuis E, Alric L, Vinel JP.

Aliment Pharmacol Ther. 2008 Jun;27(12):1261-8. doi: 10.1111/j.1365-2036.2008.03701.x. Epub 2008 Apr 4.

20.

Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis.

Colecchia A, Montrone L, Scaioli E, Bacchi-Reggiani ML, Colli A, Casazza G, Schiumerini R, Turco L, Di Biase AR, Mazzella G, Marzi L, Arena U, Pinzani M, Festi D.

Gastroenterology. 2012 Sep;143(3):646-54. doi: 10.1053/j.gastro.2012.05.035. Epub 2012 May 27.

PMID:
22643348
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk